A case of a digitate injection site reaction from subcutaneous bortezomib in a patient with myeloma
{{output}}
The proteasome inhibitor bortezomib is widely used in the treatment of multiple myeloma. While peripheral neuropathy and gastrointestinal effects are well-documented adverse reactions to bortezomib administration, cutaneous side effects in patients with multip... ...
